Markets:

Overview

News

Currencies

International

Treasuries

Zura Bio Limited - Class A Ordinary shares (NQ:ZURA)

7.000 +0.310 (+4.63%)

Official Closing Price Updated: 4:15 PM EST, Feb 25, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Zura Bio Limited - Class A Ordinary shares

< Previous 1 2 3 4 Next >

Apogee Therapeutics Stock Up 100% as Fund Lifts Stake to $28 Million ↗

Today 15:26 EST

This biotech specializes in monoclonal antibody therapies for inflammatory and immunological diseases with significant unmet needs.

Via The Motley Fool

Topics Regulatory Compliance

This Fund Bet $20 Million on RAPT Therapeutics as Stock Surges 500% This Past Year and Buyout Offer Emerges ↗

Today 15:19 EST

RAPT Therapeutics develops oral therapies for oncology and inflammatory diseases, with lead candidates progressing in clinical trials.

Via The Motley Fool

Topics Regulatory Compliance

Disc Medicine Lands New $20 Million Investment as FDA Sets Up Potential Q4 Catalyst ↗

Today 15:11 EST

This clinical-stage biotech develops therapies targeting hematologic disorders, with a pipeline centered on red blood cell biology.

Via The Motley Fool

Topics Regulatory Compliance

Zura Bio Announces Pricing of $125 Million Public Offering of Class A Ordinary Shares and Pre-Funded Warrants

Today 6:30 EST

From Zura Bio Limited

Via Business Wire

Zura Bio Announces Proposed Public Offering of Class A Ordinary Shares and Pre-Funded Warrants

February 24, 2026

From Zura Bio Limited

Via Business Wire

Zura Bio Welcomes Accomplished Drug Development Leaders Mark Eisner, M.D., M.P.H., and Ajay Nirula, M.D., Ph.D., to Board of Directors

February 23, 2026

From Zura Bio Limited

Via Business Wire

Zura Bio to Participate in the Guggenheim Emerging Outlook: Biotech Summit

February 04, 2026

From Zura Bio Limited

Via Business Wire

Zura Bio Appoints Immunology Industry Leader Sandeep Kulkarni, M.D. as Chief Executive Officer

January 21, 2026

From Zura Bio Limited

Via Business Wire

Zura Bio Reports Business Updates and Outlook for 2026

January 12, 2026

From Zura Bio Limited

Via Business Wire

Zura Bio Reports Third Quarter 2025 Financial Results and Recent Corporate Updates

November 13, 2025

From Zura Bio Limited

Via Business Wire

Unusual volume stocks are being observed in Wednesday's session. ↗

October 01, 2025

Discover the stocks with unexpected trading volume in today's session on the US markets.

Via Chartmill

Here are the top movers in Tuesday's session. ↗

September 30, 2025

Curious about what's happening in today's session? Check out the latest stock movements and price changes.

Via Chartmill

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

September 30, 2025

Via Benzinga

These stocks are moving in today's session ↗

September 30, 2025

Intrigued by the market activity in the middle of the day on Tuesday? Uncover the key winners and losers of today's session in our insightful analysis.

Via Chartmill

12 Health Care Stocks Moving In Monday's Intraday Session ↗

September 29, 2025

Gainers cbdMD (AMEX:YCBD) shares rose 116.3% to $1.35 during Monday's regular session. The company's market cap stands at $5.5 million. Zura Bio (NASDAQ: ZURA) stock moved upwards by 42.94% to $3.44....

Via Benzinga

Top stock movements in today's session. ↗

September 29, 2025

Keep an eye on the top gainers and losers in Monday's session, as they reflect the most notable price movements.

Via Chartmill

Wondering what's happening in today's pre-market session? ↗

September 29, 2025

Before the opening bell on Monday, let's take a glimpse of the US markets and explore the top gainers and losers in today's pre-market session.

Via Chartmill

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

September 29, 2025

Gainers Dogwood Therapeutics (NASDAQ: DWTX) stock moved upwards by 80.1% to $9.94 during Monday's pre-market session. The market value of their outstanding shares is at $10.5 million.

Via Benzinga

Why Merus Shares Are Trading Higher By 38%; Here Are 20 Stocks Moving Premarket ↗

September 29, 2025

Shares of Merus NV (NASDAQ: MRUS) rose sharply in today's pre-market trading. Genmab announced plans to acquire Merus for $8 billion in all-cash deal adding breakthrough therapy Petosemtamab to its...

Via Benzinga

Zura Bio to Participate in the Cantor Fitzgerald Global Healthcare Conference

August 20, 2025

From Zura Bio Limited

Via Business Wire

Zura Bio Reports Second Quarter 2025 Financial Results and Recent Corporate Updates

August 14, 2025

From Zura Bio Limited

Via Business Wire

Novartis Drug Shows Improvement In Sjögren's Disease In Late-Stage Trials: Analyst Deems Data Positive For Zura Bio As Well ↗

August 11, 2025

Novartis now sees the potential for the drug to become the first and only targeted treatment approved for patients with the disease.

Via Stocktwits

Zura Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

July 17, 2025

From Zura Bio

Via Business Wire

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

July 17, 2025

Via Benzinga

Zura Bio Announces Chief Financial Officer Transition

July 01, 2025

From Zura Bio Limited

Via Business Wire

Zura Bio to Present at the Jefferies Global Healthcare Conference

May 27, 2025

From Zura Bio Limited

Via Business Wire

Zura Bio Launches Global Phase 2 TibuSHIELD Study to Evaluate Tibulizumab in Adults with Hidradenitis Suppurativa

May 20, 2025

From Zura Bio Limited

Via Business Wire

Zura Bio Reports First Quarter 2025 Financial Results and Recent Corporate Updates

May 08, 2025

From Zura Bio Limited

Via Business Wire

Zura Bio Reports Full Year 2024 Financial Results and Recent Corporate Updates

March 25, 2025

From Zura Bio Limited

Via Business Wire

Zura Bio to Present at the Leerink Partners Global Healthcare Conference

February 24, 2025

From Zura Bio Limited

Via Business Wire

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.